Shows
Best Life Best Death#155 A Key Medical Study: Living the Most in the Time You Have Left – Dr Kerin Adelson MD Anderson and Dr Maureen Canavan YaleWhen you are in that terribly complicated time of making medical decisions around advanced cancer, what framework can you turn to? Oncologists are called upon to treat and offer options; patients hope to gain time if not be cured. What are the choices and the impact of those choices for advanced solid tumor cancers? What if I told you that two doctors have gathered the data to find out whether certain treatments extend life or not. Would you listen to that conversation to find out more? I would!2024-08-2133 min
Managed Care CastHow to Improve Quality of US Health Care: Dr Patricia Salber Interviews Dr Elizabeth McGlynnDespite decades of experimentation, there have not been large increases in health care quality in the United States. What will move the needle?
In this week’s Managed Care Cast, Elizabeth McGlynn, PhD, speaks with Patricia Salber, MD, MBA, of The Doctor Weighs In, about health care quality in the United States, quality measurement and incentives, what the United States can do to drive quality improvement, how social determinants fit into the picture, and more.
McGlynn serves as Kaiser Permanente Bernard J. Tyson School of Medicine’s Interim Senior Associate Dean for Research and Scholarships and as a professor. She is a...2020-09-2943 min
Engaging Experts by Journal of Clinical PathwaysPatient-Centered Care, PROs, and Pathways at Yale Cancer CenterYale Cancer Center’s Kerin Adelson, MD, chief quality officer, and Dena Schulman-Green, PhD, gerontologist and palliative care researcher, discuss the patient-centered considerations within day-to-day cancer care operations and within their clinical pathways.2019-12-1721 min
JCO Oncology Practice PodcastImplementation of Electronic Chemotherapy Ordering: An Opportunity to Improve Evidence-Based Oncology Careby Robert S. Miller, MD. Dr. Kerin Adelson discusses the implementation of Epic’s Beacon chemotherapy ordering platform at the Tisch Cancer Institute of Mt. Sinai, New York, and introduces a new quality metric called the rate of evidence-based adherence (REBA), used to measure clinic and provider performance and increase evidence-based practice.2014-01-0323 min